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A B S T R A C T
There is an unmet need to develop and validate therapies that can treat or at least prevent premature therapy-
induced frailty, multi-morbidity and mortality in long-term tumour survivors. In an approach to develop a first
mouse model for therapy-induced long-term frailty, we irradiated male C57Bl/6 mice at 5–6 months of age sub-
lethally with 3×3 Gy (whole body) and assessed subsequent frailty for up to 6 months using a Rockwood-type
frailty index (FI). Frailty scorers were trained to obtain excellent inter- and intra-observer reproducibility.
Irradiated mice developed progressive frailty approximately twice as fast as controls. This was premature frailty;
it was phenotypically identical to that in non-irradiated mice at higher age. As expected, frailty was associated
with decreased cognition and predicted mortality. In irradiated mice, frailty and neuromuscular performance,
measured by Rotarod and Hanging Wire tests, were not associated with each other, probably because of long-
term decreased body weights after irradiation. We conclude that progressive frailty following sub-lethal irra-
diation comprises a sensitive and easy to use test bed for interventions to stop premature ageing in long-term
tumour survivors.
1. Introduction
Improvements in cancer treatment have rendered many common
cancers curable in a high proportion of patients. Although cancer re-
mains a common disease, affecting an estimated 18 million of the world
population in 2018, cancer-specific mortality has dropped sharply in
the last few decades in developed countries. For example more than
70% of patients with breast cancer can now expect to live more than 10
years from diagnosis and many haematological and paediatric cancers
have high cure rates (Bray et al., 2018). There is now greater awareness
of health issues in long-term survivors, and in some fields the emphasis
has started to shift towards efforts to improve the quality of survivor-
ship after successful cancer treatment (Damlaj et al., 2019). The
mainstays of adjuvant treatment i.e. radiotherapy and chemotherapy
result in long-term morbidity in a wide range of organ systems,
including cardiovascular, gastrointestinal, pulmonary, hepatic, muscu-
loskeletal and neurological effects as well as enhanced mortality, to-
gether resembling accelerated ageing (Cupit-Link et al., 2017; Robison
and Hudson, 2014). Specifically, widely used adjuvant therapies pre-
cipitate onset of frailty by about two decades of life prematurely in
long-term survivors of many different cancer types (Arora et al., 2016;
Ness et al., 2015, 2013). At present, the only approach to postpone or
lessen this therapy-induced frailty is lifestyle counselling; there are no
therapies available. To develop and validate those, mouse models of
therapy-induced frailty are urgently needed.
The concept of frailty has been developed to describe the conditions
of aged people with increased vulnerability to adverse health outcomes
and is considered to be associated with a major loss of capacity to
maintain tissue homeostasis and regeneration. It is characterized by a
state of age-related biological vulnerability to stressors and decreased
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physiological reserves with alterations in energy metabolism, decreased
skeletal muscle mass and quality, and altered hormonal and in-
flammatory functions (for review see (Mohler et al., 2014)). A con-
sensus paper defined frailty as “a medical syndrome with multiple
causes and contributors that is characterized by diminished strength
and endurance, and reduced physiologic function that increase an in-
dividual’s vulnerability for developing increased dependency and/or
death” (Morley et al., 2013).
A number of frailty scales have been developed to operationalize the
assessment of human frailty. The two major frailty models that have
been more extensively validated are the “Fried frailty phenotype” and
the “Rockwood frailty index (FI)”. Fried’s frailty phenotype defines
frailty as a distinct clinical syndrome meeting three or more of five
phenotypic criteria: weakness, slowness, low level of physical activity,
self-reported exhaustion, and unintentional weight loss (Fried et al.,
2001). In contrast, the FI defined frailty by the accumulation of deficits
in multiple domains (Rockwood et al., 2005). Deficiencies in more than
70 parameters relevant to everyday activities, also comprising physio-
logical problems, mental capabilities, concomitant features of co-mor-
bidities etc. have been included in the construction of various Rock-
wood frailty index scales. Although multi-deficiency and multi-
morbidity is an essential part of the frailty index, the specific number
and types of deficiencies included have only a minor impact on the
categorization of frailty (Song et al., 2010). Moreover, additional
parameters in excess of about 30 do not seem to increase the power of
the index greatly. While the Fried and Rockwood concepts are over-
lapping and both scales are able to predict mortality, sensitivity and
specificity regarding the classification of individuals as frail/non-frail
are somewhat different between the scoring systems (Collerton et al.,
2012; Ravindrarajah et al., 2013; Theou et al., 2013).
In recent years, both frailty models have been reverse translated
into mice (see (von Zglinicki et al., 2016) for review). Rockwood-type
frailty indices for mice have bene constructed based on either ob-
servational scoring (Whitehead et al., 2014) or quantitative measure-
ments (Antoch et al., 2017), while a Fried-type frailty syndrome for
mice is usually constructed from quantitative measurements (Baumann
et al., 2018; Martinez de Toda et al., 2018). The reliability (longitudinal
and inter-observer) of the FI scores has been validated (Feridooni et al.,
2015; Kane et al., 2015) and all scales were able to predict mortality in
mice (Antoch et al., 2017; Baumann et al., 2018; Martinez de Toda
et al., 2018; Rockwood et al., 2017). Both the scored (Kane et al., 2016)
and the quantitatively based (Antoch et al., 2017) FI have been shown
to be sensitive to longevity-modulating interventions (caloric restric-
tion, high-fat feeding, treatment with resveratrol or mTOR inhibitor) at
least in some cohorts of mice.
There is yet little data available on long-term effects of either
chemo- or radiotherapy on frailty in mice. Available mouse models of
radiation- or chemotherapy-induced fatigue cover only some aspects of
frailty and importantly are generally only evaluated over short periods,
covering essentially only the period of acute radio- or chemotoxicity
(Demaria et al., 2017; Dougherty et al., 2019; Renner et al., 2016; Wolff
et al., 2017). In one paper, running wheel activity after localized irra-
diation (single leg) has been shown to be compromised for up to seven
months (Zhu et al., 2015), but further domains of frailty were not as-
sessed. Assessing frailty according to Whitehead (Whitehead et al.,
2014) longitudinally, we show here that sub-lethal whole-body irra-
diation induces progressive premature frailty in mice. Radiation-in-
duced frailty predicts severe morbidity precipitating mortality and is
associated with cognitive decline. Associations between frailty and
neuromuscular capability as measured by performance in rotarod and
hanging wire tests are complicated by irradiation-mediated body
weight decrease. The data suggest this as a simple, relevant test bed for
interventions aimed at preventing or relieving cancer therapy-induced
premature frailty and ageing.
2. Material and methods
2.1. Mice
Male C57Bl/6 mice were bought past weaning from Charles River
and were maintained in groups of six littermates per cage as described
(Cameron et al., 2012). Most mice were fed standard pelleted food
(CRM-P formulation rodent diet, SDS Diets), but some mice were either
gavage-fed for two weeks or received soaked food (same as above) from
one month post-IR. The work was licensed by the UK Home Office
(PB048F3A0) and complied with the guiding principles for the care and
use of laboratory animals.
2.2. Irradiation
At 5–6 months of age, mice were sub-lethally irradiated (NDT 320
or X-RAD225, 225 kV) with 3 Gy of X-ray irradiation, 3 times, with 2
days recovery time between doses. 2 days prior to IR, and for 14 days
post-IR, mice received 1% Baytril solution (Broad-spectrum antibiotic)
in drinking water.
2.3. Frailty index
Frailty was assessed as a 30-parameter index based on (Whitehead
et al., 2014). In comparison to (Whitehead et al., 2014), we did not test
the menace reflex in order to reduce the stress to the animals. More-
over, grip strength was measured using BIO-GS3 BIOSEP and the
average of 3 measurements was compared to reference values from sex-
matched adult animals. Further minor modifications in the oper-
ationalisation are indicated in Supplementary Tab. S1.
2.4. Neuromuscular tests
Hanging Wire: Animals were allowed to grip the middle of a sus-
pended plastic wire (diameter 2mm, and 30 cm in length) with their
forelimbs and let to hang. Test duration was 60 s and success was
measured as a mouse hanging through the whole test, getting all 4
limbs onto the wire (time taken recorded), or reaching the end of the
wire (time taken recorded). Failure was measured as a mouse falling
before 60 s. Mice were given up to 3 trials to succeed (spaced by 5min).
The wire was suspended 30 cm above a landing pad (20 cm depth of soft
fluffed bedding, and with a paper cover), which proved high enough to
discourage deliberate dropping but reduced the impact from falling.
Rotarod (LE8200 BIOSEP) was used to assess muscle function. Mice
were placed on the rod at an initial 4 rpm, and rotation accelerated by
7.2 rpm per minute. Maximum velocity (rpm), time on rod (sec) and
total distance (m) were recorded. Mice were tested 3 times per day, for
up to 3 days, with approximately 15min intervals between trials.
2.5. Cognition
Two protocols were used with separate Y-Mazes: Forced
Alternation, and Spontaneous Alternation. For forced alternation, the Y-
maze was made from white plastic. Each arm was 40 cm long, 8 cm
wide, and 15 cm high with a curved lip. The end of each arm was
marked with a black icon (+,▪, o). The home cage was moved into the
test room for one hour prior to testing to allow mice to acclimatise.
Experiments were performed in 80 lx light to allow for video recording.
During acquisition, one of the arms (▪ or o) was blocked off by a white
barrier. The mouse was placed in the home arm (+) and given 10min
to explore the two open arms of the maze (home and familiar arms).
After this, the mouse was returned to the home cage for a 1 h inter-trial
period. The maze was cleaned thoroughly with 70% EtOH between
trials to remove odours. Up to 5 mice could be tested at a time. After
1 h, the mouse was placed in the home arm, with the blocked off arm
(novel arm) opened and all 3 arms (home, familiar and novel arms)
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open to explore for 5min. If the mouse climbed out of the maze, it was
returned to the abandoned spot. Time taken for mice to enter the novel
arm was recorded.
The Spontaneous Alternation Y-maze was performed in a separate
Y-maze, made of dark grey plastic, each arm 40 cm long, 5 cm wide and
10 cm high. Mice were placed in arm 1, and order of arm entry was
manually recorded for 5min in low light conditions (˜1 lx). A sponta-
neous alternation is defined as a mouse entering a different arm of the
maze in each 3 consecutive entries, spontaneous alternation frequency
is calculated as the number of spontaneous alternations, divided by
total number of arm entries -2.
2.6. Statistics
Non-normally distributed data were presented as box-and-whisker
plots with boxes indicating median and upper/lower quartiles, whiskers
indicating upper/lower percentiles and outliers shown. These data were
compared by Mann-Whitney Rank Sum test. Multiple groups were
compared by ANOVA or, if the data failed an equal variance test, by
ANOVA on ranks, followed by post-hoc tests (Holm-Sidak or Dunn’s).
Survival was assessed by Kaplan-Meier Analysis, comparing groups by
Log-Rank test. All correlations were assumed as linear and assessed by
Pearson’s statistics.
3. Results and discussion
3.1. Establishing reproducibility in FI scoring
To enable meaningful assessment of FI scores during longitudinal
ageing studies, both intra- and inter-scorer reproducibility has to be
established. We trained three lab members (a postdoc, a PhD student
and a technician, all with previous experience in mouse husbandry, but
only the post-doc with previous experience in frailty assessment) to
perform frailty assessments interchangeably based on the same oper-
ationalisation. Over a course of six weeks, weekly frailty assessments
were performed by the three scorers as a group, during which the op-
erationalisation of the scoring was discussed and modified towards a
finally agreed version. Afterwards, each assessor scored a group of 20
mice independently without interaction with the others. Post-hoc ana-
lysis showed very good correlations between scores from all three ob-
servers (Fig. 1A–C). Another group of mice was scored by the same
observer twice over the course of 2 weeks. The second scoring was done
without access to the results of the first. Both data sets were in excellent
accordance (Fig. 1D).
The inter-rater reliability achieved by this training period (Fig. 1)
exceeded those reported by two independent groups previously
(Feridooni et al., 2015; Kane et al., 2015). To ensure consistence with
ongoing and future studies, new observers will only be added to the
scorer pool after being similarly trained by at last one member of the
original group and after establishing reproducibility.
3.2. Whole body irradiation causes premature frailty
For this study, 88 mice were irradiated with 3 times 3 Gy in four
cohorts at 5–6 months of age (between days 140 and 181). One mouse
had to be culled due to acute radiation sickness before the first frailty
assessment. In all other mice, indicators of acute radiation thickness
(mild to moderate weight loss, white toes) abated within a month and
post-IR frailty was scored about every two months. Mortality was
progressively high (see below): 2 mice had to culled between first and
second frailty assessment, and 10 more before the third, mostly due to
tumours (thymoma). Frailty scores in the irradiated mice were com-
pared to a group of 12 mice that were sham-irradiated at 6 months of
age as well as to a group of 15 non-irradiated mice at 22 months of age
(Fig. 2A). Frailty scores assessed in the latter group by us were quan-
titatively equal to those described by others in the same strain and age
Fig. 1. Inter- and intra-scorer reproducibility of FI scores. A–C) FI scores for
individual mice obtained by three different observers independently. Mice were
7 months old, half of them had been irradiated at 5 months of age. D) FI scores
obtained by the same observer longitudinally at time points 2 weeks apart. Data
are from two groups of 12 mice each at 5 and 22 months of age. Pearsons’ linear
correlation coefficients r are shown.
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(Kane et al., 2016; Rockwood et al., 2017). Already at 2 months post IR,
the FI in the irradiated mice was higher than in the control, and it
increased progressively at about twice the control rate, reaching a level
similar to that of 22 months old non-irradiated animals already at 11
months of age (Fig. 2A).
A comparison of the individual domains of the FI between 11
months old irradiated and 22 months old non-irradiated mice revealed
deficiencies in exactly the same domains in both groups of mice
Fig. 2. Whole-body IR causes premature frailty in
mice. A) C57Bl/6 male mice were irradiated or sham-
irradiated at 5–6 months of age and frailty was scored at
the indicated time points. Scoring was done long-
itudinally with the exception of the 22 months old ani-
mals (n=15). Other data are from 87 irradiated and 12
sham-irradiated mice. *** p < 0.001, Mann-Whitney
Rank Sum test. B) Irradiation-induced frailty domains are
similar to those found in old mice. Heatmap shows scores
for all 30 frailty domains in 12 young sham-irradiated
mice (left), 71 irradiated mice at 11 months of age
(middle) and 14 22 months old non-irradiated mice.
Scores are 0 (green), 0.5 (yellow) or 1 (red).
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(Fig. 2B). Frailty precipitated by IR develops faster but is phenotypi-
cally equal to frailty associated with the ‘normal’ ageing process. In
other words, whole-body irradiation causes progressive premature
frailty. This is important because it implies that irradiated mice con-
stitute a valid model to test interventions aimed at preventing or curing
age-related frailty but at about half the time and costs that would
normally be necessary.
3.3. Radiation-induced frailty predicts mortality
The FI predicts mortality risk in both humans and mice (Rockwood
et al., 2017). Accordingly, in our cohort, irradiated mice showed not
only premature frailty but also enhanced mortality (Fig. 3A). It should
however be stressed that the concept of mortality in mice is very dif-
ferent from humans: mice are being humanely killed if they show signs
of significant distress such that ‘natural’ death occurs only as a very rare
exception. Therefore, mortality in mice is much more closely associated
with morbidity than in humans. From our cohort of 88 irradiated mice,
15 had to be culled during the observation period of 412 days. Of these,
one mouse as culled because of severe acute radiation sickness within
days after irradiation and was excluded from Fig. 3A. 3 animals were
culled because of swollen, inflamed legs, probably caused by fight
wounds and one mouse developed a sore penis and prolapse. The vast
majority (11 out of 15) of mice presented with tumours, mostly thy-
momas.
When irradiated mice were stratified according to the median frailty
index measured at 4 months post-IR, a suggestive albeit not significant
difference in survival was seen (Fig. 3B). However, body mass, mea-
sured at the same time point as this second post-IR frailty assessment,
was a significant predictor of survival (Fig. 3C). This difference in
predictive power might be due to the fact that follow-up time in our
cohorts was relatively short (median follow-up age 251 days, maximum
age 412 days). Low body mass and especially fast weight loss is a well-
established predictor of immanent death in both humans (Fried et al.,
2001) and mice (Jurk et al., 2014). It might be possible that the FI
would gain better predictive power over a longer prospective period.
We next examined the associations between frailty index and neu-
romuscular coordination, measured by Rotarod and Hanging Wire tests
that were performed in parallel to the frailty assessments. In sham-ir-
radiated mice, the expected inverse association between frailty and
maximum obtainable speed on a Rotarod was seen (Fig. 3D). Un-
expectedly, irradiated mice, despite being more frail (see Fig. 2A), did
not show lower performance in either test at any time (data not shown).
The association between FI and Rotarod performance in irradiated mice
was actually borderline positive at 4 months post-IR and did not be-
come inverse even at 6 months post-IR (Fig. 3E). Similar results were
obtained when time on the rod or distance travelled were considered
(data not shown). Moreover, success or failure in the Hanging Wire test
was not dependent on frailty levels in either 9 months old (Fig. 3F) or
11 months old (Fig. 3G) irradiated mice. If anything, there was a ten-
dency for an association of lower frailty levels with test failure in the
younger mice (Fig. 3F), again contrary to expectations. Similarly, (Kane
et al., 2016) did not find a correlation between frailty index and neu-
romuscular performance in subgroups of their calorie restricted or re-
sveratrol-treated mice. Associations between body mass and functional
performance measures were not reported in this study.
Body mass is a significant negative determinant of performance in
neuromuscular tests (Graber et al., 2013) and remained lower in
Fig. 3. Radiation-induced premature frailty predicts mortality but not loss of neuromuscular coordination. A) Kaplan-Meyer survival curves for irradiated vs
non-irradiated male C57Bl/6 mice. Data are from 87 irradiated and 261 non-irradiated mice. Irradiation was started between 140 and 181 days of age. p < 0.001. B)
Survival of irradiated mice split according to their FI median value (0.117) measured at about 4 months post IR. C) Survival of irradiated mice split according to their
body mass median value (35.7 g) measured at about 4 months post IR. D) Association between FI and maximum rotarod speed in sham-irradiated mice at 9 months of
age. p=0.008. E) Association between FI and maximum rotarod speed in irradiated mice at 9 months of age (4 months past IR, black, p=0.055) and at 11 months
of age (red, p=0.114). F) FI in irradiated mice at about 4 months past IR that succeeded (left) or failed (right) the hanging wire test. p= 0.059. G) FI in irradiated
mice at about 6 months past IR that succeeded (left) or failed (right) the hanging wire test. p= 0.258.
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irradiated mice over the whole post-IR observation period (suppl. Fig.
S1). Our results confirm low body mass as a major predictor of good
physical performance and low frailty at younger biological age, i.e. in
sham-irradiated mice (suppl. Fig. S2A, B). However, at more advanced
biological age, low body mass becomes a predictor of increased frailty
and mortality risk in humans (Fried et al., 2001) and mice (Jurk et al.,
2014). Accordingly, in the irradiated mice body weight still negatively
predicts Rotarod performance at 9 months of age but the correlation is
lost at 11 months (Suppl. Fig. S2C). Similarly, low body mass predicts
success in the hanging wire test at the earlier but not the later age
(suppl. Fig. S2E, F). The association of body mass with frailty is lost in
irradiated mice already at 9 months of age (suppl. Fig. S2D). Together,
these data show that body mass is a potentially major but complex
confounder of the association between frailty and neuromuscular per-
formance. Given that large weight differences between sham-treated
and irradiated mice persist for many months after irradiation (suppl.
Fig. S1), we would argue against normalising performance measures by
body weight as this might introduce apparent but artificial differences
in performance.
3.4. Radiation-induced frailty is associated with decreased cognition
We tested cognition in parallel with the last frailty assessment by
two versions of the Y maze test, measuring i) the time it took a mouse to
enter the novel arm in a forced alternation experiment (Fig. 4A) and ii)
the alternation frequency in a spontaneous alternation set-up (Fig. 4B).
In both tests, irradiated mice performed worse than sham-treated ones
(Fig. 4A, B). The FI at the time of cognitive assessment predicted these
differences in cognition at single animal level (Fig. 4C, D). However, FI
values assessed at an earlier time point (i.e. at 4 months post-IR) did not
prospectively predict cognitive performance (data not shown).
Y maze performance may be compromised by vision impairment or
loss of whiskers, both of which were absent in the sham-irradiated mice
but were found in some of the irradiated animals. Thus, lower perfor-
mance in the maze post irradiation might simply reflect these sensory
organ impairments rather than decreased cognition. To address this
possibility, we separated the Y maze results in the irradiated mice ac-
cording to their whisker and vision status (suppl. Fig. S3). Irradiated
mice still showed delayed entry into the novel arm even when they
retained whiskers (suppl. Fig. S3A) and with intact vision (suppl. Fig.
S3C). However, the reduced ability of irradiated mice to discriminate
between maze arms in a spontaneous alternation experiment was no
longer significant when physically impaired mice were separated out
(suppl. Fig. S3B, D). Correlations between FI and Y maze performance
remained weakly significant for mice that retained their whiskers
(p= 0.047 for FI vs time; p=0.096 for FI vs alternation frequency).
For mice with unimpaired vision, the correlation between FI and time
remained significant (p= 0.007), but FI and alternation frequency
were no longer correlated (p=0.132). Together, these data show that
loss of whiskers or vision impairment contribute to lower performance
of irradiated mice in the Y maze to some extent. However, irradiated
mice without such sensory organ impairments also performed worse in
at least some of the tests, suggesting an independent effect of irradia-
tion on cognition.
3.5. Conclusions
We show here that fractionated, sub-lethal irradiation causes pre-
mature frailty, cognitive decline and premature mortality, mostly as-
sociated with early tumour development. Already within two months
after irradiation, the frailty index according to (Whitehead et al., 2014)
is significantly enhanced and increases progressively with time. This
index is easy, fast and cheap to assess, can be measured longitudinally
and is highly reproducible following a short training programme. It
provides a simple model for testing and pre-clinical validation of in-
terventions aimed to treat therapy-induced premature ageing in long-
term cancer survivors.
Limitations of our study include that it has been done in one strain
of mice only and only in males. It will now be important to address the
question whether localized irradiation, simulating more closely a
cancer therapeutic situation, also causes progressive frailty in mice.
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